dr. pal on preoperative immunotherapy in patients with rcc
Published 7 years ago • 124 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:15
dr pal on the preliminary efficacy of dff332 in advanced ccrcc
-
1:01
dr. pal on sequencing challenges for the treatment of patients with rcc
-
0:48
dr. pal discusses the role of pd-l1 in metastatic rcc
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
1:52
dr. powles on monitoring immunotherapy effects in patients with rcc
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
0:43
dr. pal on sequencing nivolumab in rcc
-
38:47
renal cell carcinoma
-
56:59
renal cell carcinoma
-
26:48
immunotherapy in treating kidney cancer
-
1:02
dr. sznol on immunotherapy in patients with rcc
-
1:31
dr. pal on biomarker development in renal cell carcinoma
-
1:33
dr. infante on am00100 in patients with rcc
-
2:00
dr. pal on adjuvant therapy of renal cell carcinoma
-
1:33
dr. pal on the checkmate-214 and cabosun studies in rcc
-
0:41
dr. pal on molecular signatures in renal cell carcinoma
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
0:51
dr. pal on the frontline approval of nivolumab and ipilimumab in mrcc
-
1:06
dr. pal on crispr-based technology in rcc
-
1:02
dr. choueiri on the research with immunotherapy in rcc
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
1:23
dr. lee on immunotherapy's future in rcc